2.Post-Surgery Chemotherapy Improves Survival in Early Lung Cancer (Posted: 06/05/2004) - Two large randomized studies show that in early-stage non-small cell lung cancer, treatment after surgery with chemotherapy improves overall survival compared to surgery alone. The findings help resolve a controversy over the value of post-surgical chemotherapy for early lung cancer and are likely to change the standard of care.
3.Erlotinib (Tarceva®) Extends Survival in Advanced Lung Cancer (Posted: 06/05/2004) - Erlotinib (Tarceva®) prolonged survival in patients with advanced non-small cell lung cancer who had progressed after standard chemotherapy, according to findings reported at the 2004 ASCO meeting in New Orleans.
4.Pemetrexed (Alimta®) Is a Less-Toxic Alternative for Recurrent Lung Cancer (Posted: 06/12/2003, Updated: 05/05/2004) - The experimental drug pemetrexed (Alimta®) was as effective as the current standard treatment for recurrent non-small cell lung cancer (NSCLC) and caused fewer side effects, according to data presented at American Society of Clinical Oncology (ASCO) annual meeting on June 2, 2003.